Experiment

Accelerating the Fight 
Against Oral Cancer with Novel Diagnostic Technology

ORAL CANCER DIAGNOSTIC.  EARLY MATTERS

Who We Are
 

Basin Genomics is an early stage healthcare company whose mission is to provide novel technology for the early detection of oral cancer.

Founded in 2018, our goal is to increase the accessibility and efficacy of oral cancer testing to improve health outcomes on a global scale

What We Do
 

With a unified focus & commitment across our organization, we are laser-focused on commercializing a cutting-edge test for oral cancer.

 

The early detection of precancerous cellular changes will assist clinicians in selecting the most appropriate treatment options for their patients.

Why We're Doing It

It’s simple. By finding oral cancer early, it will save lives– and reduce the physical, emotional, and financial effects of late-stage diagnosis in the process.  We strongly believe personalized oral cancer diagnostics is within reach.

 

Connect with us to learn more.

Oral Cancer Does Not Discriminate

CONTACT US

ORAL CANCER DIAGNOSTIC.  EARLY MATTERS

Thanks for submitting!